Predicting Chemotherapy Toxicity in Older Patients with Cancer: A Multicenter Prospective Study.
Jaime Feliú-BatlleBeatriz Jiménez-MunárrizLaura BasterretxeaIrene ParederoElisenda LlabrésMaite Antonio-RebolloBeatriz LosadaEnrique EspinosaRegina GironésAna Belén CustodioMaría Del Mar MuñozMariana Díaz-AlmirónJeniffer Gómez-MediavillaAlvaro PintoMaría-Dolores TorregrosaGema SolerPatricia CruzOliver HigueraMaría José Molina-GarridoPublished in: The oncologist (2020)
Older patients are more vulnerable to chemotherapy toxicity. However, standard tools are inadequate to identify who is at higher risk of developing chemotherapy-related complications. Chemotherapy doses (standard vs. reduced) and renal function were identified as the major risk factors for developing severe toxicity in the elderly. These factors should be considered when planning to initiate a new chemotherapy regimen and should also lead to a closer follow-up.